Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


Articles published in J Rheumatol

Retrieve available abstracts of 181 articles:
HTML format
Text format



Single Articles


    June 2018
  1. XIE L, Xu J
    Role of MiR-98 and Its Underlying Mechanisms in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jun 15. pii: jrheum.171290. doi: 10.3899/jrheum.171290.
    PubMed     Text format     Abstract available


  2. TROLDBORG A, Thiel S, Trendelenburg M, Friebus-Kardash J, et al
    The Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jun 15. pii: jrheum.171033. doi: 10.3899/jrheum.171033.
    PubMed     Text format     Abstract available


  3. ZAMPELI E, Skopouli FN, Moutsopoulos HM
    Polyserositis in a Patient with Active Systemic Lupus Erythematosus: A Case of Pseudo-pseudo Meigs Syndrome.
    J Rheumatol. 2018;45:877-878.
    PubMed     Text format    


  4. FONGAUFIER C, Guffroy A, Lutz JC
    Tongue and Scalp Necrosis: Simultaneous Initial Complications Revealing Giant Cell Arteritis.
    J Rheumatol. 2018;45:873-874.
    PubMed     Text format    


  5. LABRADOR-HORRILLO M, Selva-O'Callaghan A
    Cancer-associated Dermatomyositis: Does the PD-1 Checkpoint Pathway Play a Role?
    J Rheumatol. 2018;45:731-732.
    PubMed     Text format    


  6. TSELIOS K, Gladman DD, Touma Z, Su J, et al
    Monophasic Disease Course in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jun 1. pii: jrheum.171319. doi: 10.3899/jrheum.171319.
    PubMed     Text format     Abstract available


  7. GUDERUD K, Maehlen MT, Nordang GBN, Viken MK, et al
    Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies, PADI4 Polymorphisms, and Clinical Characteristics in Rheumatoid Arthritis.
    J Rheumatol. 2018 Jun 1. pii: jrheum.170769. doi: 10.3899/jrheum.170769.
    PubMed     Text format     Abstract available


    April 2018
  8. RAISSI TC, Hewson C, Pope JE
    Repeat Testing of Antibodies and Complements in Systemic Lupus Erythematosus: When Is It Enough?
    J Rheumatol. 2018 Apr 15. pii: jrheum.161365. doi: 10.3899/jrheum.161365.
    PubMed     Text format     Abstract available


  9. NANGIT A, Lin C, Ishimori ML, Spiegel BMR, et al
    Causes and Predictors of Early Hospital Readmission in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170176. doi: 10.3899/jrheum.170176.
    PubMed     Text format     Abstract available


  10. TANHA N, Hansen RB, Nielsen CT, Faurschou M, et al
    Clinical and Serological Associations with the Development of Incident Proteinuria in Danish Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170933. doi: 10.3899/jrheum.170933.
    PubMed     Text format     Abstract available


  11. KAWASUMI H, Katsumata Y, Nishino A, Hirahara S, et al
    Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody-positive Cases.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170997. doi: 10.3899/jrheum.170997.
    PubMed     Text format     Abstract available


  12. VEGA-MORALES D, Hernandez-Galarza IJ, Galarza-Delgado DA
    Causes of Hospital Mortality in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus in a University Hospital: 1998-2015 Analysis.
    J Rheumatol. 2018;45:583-584.
    PubMed     Text format    


    March 2018
  13. ROMERO-DIAZ J, Acosta-Hernandez RI, Criales-Vera S, Kimura-Hayama E, et al
    Asymptomatic Coronary Artery Calcifications in Men with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170330. doi: 10.3899/jrheum.170330.
    PubMed     Text format     Abstract available


  14. YANG J, Yang X, Yang J, Li M, et al
    Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170737. doi: 10.3899/jrheum.170737.
    PubMed     Text format     Abstract available


  15. LIOZON E, de Boysson H, Dalmay F, Gondran G, et al
    Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170455. doi: 10.3899/jrheum.170455.
    PubMed     Text format     Abstract available


  16. FRITZLER MJ, Choi MY, Mahler M
    The Antinuclear Antibody Test in the Diagnosis of Antisynthetase Syndrome and Other Autoimmune Myopathies.
    J Rheumatol. 2018;45:444-445.
    PubMed     Text format    


  17. BHANSING KJ, VAN Rosmalen MH, VAN Engelen BG, VAN Riel PL, et al
    Ultrasound: A Potential Tool for Detecting of Fasciitis in Dermatomyositis and Polymyositis.
    J Rheumatol. 2018;45:441-442.
    PubMed     Text format    


  18. TIDWELL WJ, Callen JP
    Koebner Phenomenon in Juvenile Dermatomyositis.
    J Rheumatol. 2018;45:437.
    PubMed     Text format    


  19. DAVIDSON JE, Fu Q, Ji B, Rao S, et al
    Renal Remission Status and Longterm Renal Survival in Patients with Lupus Nephritis: A Retrospective Cohort Analysis.
    J Rheumatol. 2018 Mar 1. pii: jrheum.161554. doi: 10.3899/jrheum.161554.
    PubMed     Text format     Abstract available


    February 2018
  20. YUE C, Li G, Wen Y, Li X, et al
    Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
    J Rheumatol. 2018 Feb 15. pii: jrheum.170561. doi: 10.3899/jrheum.170561.
    PubMed     Text format     Abstract available


  21. CAI F, Han F, Wang H, Han H, et al
    The Crescentic Implication of Renal Outcomes in Proliferative Lupus Nephritis.
    J Rheumatol. 2018 Feb 15. pii: jrheum.170553. doi: 10.3899/jrheum.170553.
    PubMed     Text format     Abstract available


  22. KASTURI S, Szymonifka J, Burket JC, Berman JR, et al
    Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Feb 1. pii: jrheum.170590. doi: 10.3899/jrheum.170590.
    PubMed     Text format     Abstract available


  23. CHEN H, Peng Q, Yang H, Yin L, et al
    Increased Levels of Soluble Programmed Death Ligand 1 Associate with Malignancy in Patients with Dermatomyositis.
    J Rheumatol. 2018 Feb 1. pii: jrheum.170544. doi: 10.3899/jrheum.170544.
    PubMed     Text format     Abstract available


  24. ALEXANDERSON H, Regardt M, Ottosson C, Alemo Munters L, et al
    Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective Study.
    J Rheumatol. 2018 Feb 1. pii: jrheum.161183. doi: 10.3899/jrheum.161183.
    PubMed     Text format     Abstract available


  25. LUCAS S, Chang WL, Merien F
    Prevalence and Clinical Significance of Anti-DFS70 in Antinuclear Antibody (ANA)-positive Patients Undergoing Routine ANA Testing in a New Zealand Public Hospital.
    J Rheumatol. 2018;45:289-291.
    PubMed     Text format    


  26. CHEN YH, Lu CC, Chen HC
    Candida albicans Pyomyositis in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2018;45:286-287.
    PubMed     Text format    


    January 2018
  27. BERNATSKY S, Ramsey-Goldman R, Petri M, Urowitz MB, et al
    Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jan 15. pii: jrheum.170652. doi: 10.3899/jrheum.170652.
    PubMed     Text format     Abstract available


    December 2017
  28. YEUNG Y, Barra LJ
    Cardiovascular Risk Prevention in a Canadian Population of Patients with Giant Cell Arteritis.
    J Rheumatol. 2017;44:1942-1943.
    PubMed     Text format    


  29. NAVRATIL M, Ivkovic Jurekovic I
    Chloroquine Toxicity Misdiagnosed as Fabry Disease Associated with Systemic Lupus Erythematosus and Hashimoto Thyroiditis.
    J Rheumatol. 2017;44:1940.
    PubMed     Text format    


  30. BLOCKMANS D
    Fluorodeoxyglucose Positron Emission Tomography for Giant Cell Arteritis.
    J Rheumatol. 2017;44:1763-1764.
    PubMed     Text format    


    November 2017
  31. PAKCHOTANON R, Gladman DD, Su J, Urowitz MB, et al
    More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170645. doi: 10.3899/jrheum.170645.
    PubMed     Text format     Abstract available


  32. RICHTER JG, Muth T, Li J, Brinks R, et al
    Elevated Psychosocial Stress at Work in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170233. doi: 10.3899/jrheum.170233.
    PubMed     Text format     Abstract available


  33. CHEN HL, Shen LJ, Hsu PN, Shen CY, et al
    Cumulative Burden of Glucocorticoid-related Adverse Events in Patients with Systemic Lupus Erythematosus: Findings from a 12-year Longitudinal Study.
    J Rheumatol. 2017 Nov 15. pii: jrheum.160214. doi: 10.3899/jrheum.160214.
    PubMed     Text format     Abstract available


  34. TSELIOS K, Gladman DD, Su J, Ace O, et al
    Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study.
    J Rheumatol. 2017 Nov 1. pii: jrheum.161121. doi: 10.3899/jrheum.161121.
    PubMed     Text format     Abstract available


    October 2017
  35. VITIELLO G, Cammelli D
    Large-vessel Involvement and Varicella Zoster Virus Vasculopathy in Giant Cell Arteritis-related Stroke: Something to Keep an Eye On.
    J Rheumatol. 2017;44:1566.
    PubMed     Text format    


  36. CHEN Y, Liu J
    What is the Definition of the Anticytoplasmic Autoantibody?
    J Rheumatol. 2017;44:1564.
    PubMed     Text format    


    September 2017
  37. ROSSIDES M, Simard JF, Svenungsson E, von Euler M, et al
    Mortality and Functionality after Stroke in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170241. doi: 10.3899/jrheum.170241.
    PubMed     Text format     Abstract available


  38. CLIFFORD AH, Murphy EM, Burrell SC, Bligh MP, et al
    Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170138. doi: 10.3899/jrheum.170138.
    PubMed     Text format     Abstract available


  39. BONEPARTH A, Radhakrishna SM, Greenbaum LA, Yen E, et al
    Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170502. doi: 10.3899/jrheum.170502.
    PubMed     Text format     Abstract available



  40. Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
    J Rheumatol. 2017;44:1417.
    PubMed     Text format    


  41. KUMTHEKAR A, Danve A, Deodhar A
    Use of Belimumab throughout 2 Consecutive Pregnancies in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2017;44:1416-1417.
    PubMed     Text format    


  42. NANTES SG, Su J, Dhaliwal A, Colosimo K, et al
    Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Sep 1. pii: jrheum.161125. doi: 10.3899/jrheum.161125.
    PubMed     Text format     Abstract available


  43. ZOHOURY N, Bertolaccini ML, Rodriguez-Garcia JL, Shums Z, et al
    Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of "Non-criteria" Antiphospholipid Antibodies.
    J Rheumatol. 2017 Sep 1. pii: jrheum.170044. doi: 10.3899/jrheum.170044.
    PubMed     Text format     Abstract available


    August 2017
  44. BERNATSKY S, Clarke AE, Niaki OZ, Labrecque J, et al
    Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Aug 1. pii: jrheum.170179. doi: 10.3899/jrheum.170179.
    PubMed     Text format     Abstract available


    July 2017
  45. CHEN Z, Wang Y, Kuwana M, Xu X, et al
    HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis.
    J Rheumatol. 2017 Jul 15. pii: jrheum.170165. doi: 10.3899/jrheum.170165.
    PubMed     Text format     Abstract available


  46. HOZUMI H, Fujisawa T, Enomoto N, Nakashima R, et al
    Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
    J Rheumatol. 2017 Jul 15. pii: jrheum.170373. doi: 10.3899/jrheum.170373.
    PubMed     Text format     Abstract available


  47. NAGASHIMA T, Iwamoto M, Minota S
    Gottron Sign with Ulceration Is Not a Poor Prognostic Factor in Patients with Dermatomyositis and Interstitial Lung Disease.
    J Rheumatol. 2017;44:1099-1100.
    PubMed     Text format    


  48. YAP DYH, Tang C, Ma MKM, Mok MMY, et al
    Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years.
    J Rheumatol. 2017 Jul 1. pii: jrheum.170226. doi: 10.3899/jrheum.170226.
    PubMed     Text format     Abstract available


    June 2017
  49. BRUNNER HI, Bennett MR, Gulati G, Abulaban K, et al
    Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults.
    J Rheumatol. 2017 Jun 15. pii: jrheum.161128. doi: 10.3899/jrheum.161128.
    PubMed     Text format     Abstract available


  50. GU K, Gladman DD, Su J, Urowitz MB, et al
    Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center.
    J Rheumatol. 2017 Jun 15. pii: jrheum.170072. doi: 10.3899/jrheum.170072.
    PubMed     Text format     Abstract available


  51. KURTZMAN DJB, Weinblatt M, Vleugels RA
    Antimelanoma Differentiation-associated Gene 5 Dermatomyositis.
    J Rheumatol. 2017;44:850-851.
    PubMed     Text format    


  52. TARABORELLI M, Reggia R, Dall'Ara F, Fredi M, et al
    Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study.
    J Rheumatol. 2017 Jun 1. pii: jrheum.161364. doi: 10.3899/jrheum.161364.
    PubMed     Text format     Abstract available


  53. HEMKE R, Tzaribachev N, Nusman CM, van Rossum MAJ, et al
    Magnetic Resonance Imaging (MRI) of the Knee as an Outcome Measure in Juvenile Idiopathic Arthritis: An OMERACT Reliability Study on MRI Scales.
    J Rheumatol. 2017 Jun 1. pii: jrheum.160821. doi: 10.3899/jrheum.160821.
    PubMed     Text format     Abstract available


    May 2017
  54. QUARTUCCIO L, Baldini C, Priori R, Bartoloni E, et al
    Cryoglobulinemia in Sjogren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue.
    J Rheumatol. 2017 May 15. pii: jrheum.161465. doi: 10.3899/jrheum.161465.
    PubMed     Text format     Abstract available


  55. FASANO S, Pierro L, Pantano I, Iudici M, et al
    Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 May 15. pii: jrheum.161351. doi: 10.3899/jrheum.161351.
    PubMed     Text format     Abstract available


  56. NAKABO S, Yoshifuji H, Hashimoto M, Imura Y, et al
    Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.
    J Rheumatol. 2017 May 15. pii: jrheum.161432. doi: 10.3899/jrheum.161432.
    PubMed     Text format     Abstract available


  57. SHI J, Li S, Yang H, Zhang Y, et al
    Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
    J Rheumatol. 2017 May 1. pii: jrheum.161480. doi: 10.3899/jrheum.161480.
    PubMed     Text format     Abstract available


  58. LE PENDU C, Meignin V, Gonzalez-Chiappe S, Hij A, et al
    Poor Predictive Value of Isolated Adventitial and Periadventitial Infiltrates in Temporal Artery Biopsies for Diagnosis of Giant Cell Arteritis.
    J Rheumatol. 2017 May 1. pii: jrheum.170061. doi: 10.3899/jrheum.170061.
    PubMed     Text format     Abstract available


  59. KOSTER MJ, Achenbach SJ, Crowson CS, Maradit-Kremers H, et al
    Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study.
    J Rheumatol. 2017 May 1. pii: jrheum.161516. doi: 10.3899/jrheum.161516.
    PubMed     Text format     Abstract available


  60. MURO Y, Iwata N, Tanaka Y, Kodera M, et al
    Anti-dense Fine Speckled 70 Autoantibodies in Japanese Children with Dermatomyositis, Localized Scleroderma, and Idiopathic Arthritis with Iridocyclitis.
    J Rheumatol. 2017;44:711-712.
    PubMed     Text format    


  61. GENEST G, Laskin CA
    Safety and Efficacy of in Vitro Fertilization in Women with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
    J Rheumatol. 2017;44:547-549.
    PubMed     Text format    


    April 2017
  62. KASTURI S, Szymonifka J, Burket JC, Berman JR, et al
    Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Apr 15. pii: jrheum.161202. doi: 10.3899/jrheum.161202.
    PubMed     Text format     Abstract available


  63. SIMONINI G, Bracaglia C, Cattalini M, Taddio A, et al
    Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161336. doi: 10.3899/jrheum.161336.
    PubMed     Text format     Abstract available


  64. BERNTSEN KS, Tollisen A, Schwartz T, Kirkhus E, et al
    Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement.
    J Rheumatol. 2017 Apr 1. pii: jrheum.160997. doi: 10.3899/jrheum.160997.
    PubMed     Text format     Abstract available


  65. GUERRA F, Gelardi C, Capucci A, Gabrielli A, et al
    Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161311. doi: 10.3899/jrheum.161311.
    PubMed     Text format     Abstract available


  66. YANG N, Bhattacharyya S, Weinblatt M
    Refractory Syndrome of Inappropriate Secretion of Antidiuretic Hormone in Systemic Lupus Erythematosus-associated Hypophysitis.
    J Rheumatol. 2017;44:541-542.
    PubMed     Text format    


  67. NIHTYANOVA SI, Denton CP
    Scleroderma Lung Involvement, Autoantibodies, and Outcome Prediction: The Confounding Effect of Time.
    J Rheumatol. 2017;44:404-406.
    PubMed     Text format    


    March 2017
  68. ARTIM-ESEN B, Sahin S, Cene E, Sahinkaya Y, et al
    Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey.
    J Rheumatol. 2017 Mar 15. pii: jrheum.160340. doi: 10.3899/jrheum.160340.
    PubMed     Text format     Abstract available


  69. YUN H, Xie F, Baddley JW, Winthrop K, et al
    Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases.
    J Rheumatol. 2017 Mar 15. pii: jrheum.160685. doi: 10.3899/jrheum.160685.
    PubMed     Text format     Abstract available


  70. KIM SK, Choe JY, Lee SS
    Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
    J Rheumatol. 2017 Mar 15. pii: jrheum.160900. doi: 10.3899/jrheum.160900.
    PubMed     Text format     Abstract available


  71. TANNA A, Pusey CD
    The Histopathological Classification of ANCA-associated Glomerulonephritis Comes of Age.
    J Rheumatol. 2017;44:265-267.
    PubMed     Text format    


  72. TUNNICLIFFE DJ, Singh-Grewal D, Craig JC, Howell M, et al
    Healthcare and Research Priorities of Adolescents and Young Adults with Systemic Lupus Erythematosus: A Mixed-methods Study.
    J Rheumatol. 2017 Mar 1. pii: jrheum.160720. doi: 10.3899/jrheum.160720.
    PubMed     Text format     Abstract available


  73. ZISMAN D, Gladman DD, Stoll ML, Strand V, et al
    The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.
    J Rheumatol. 2017;44:342-351.
    PubMed     Text format     Abstract available


  74. HORTON DB, Onel KB, Beukelman T, Ringold S, et al
    Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
    J Rheumatol. 2017;44:352-360.
    PubMed     Text format     Abstract available


  75. WARD TM, Beebe DW, Chen ML, Landis CA, et al
    Sleep Disturbances and Neurobehavioral Performance in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2017;44:361-367.
    PubMed     Text format     Abstract available


  76. VAN DAALEN EE, Rahmattulla C, Wolterbeek R, Bruijn JA, et al
    Incidence of Malignancy Prior to Antineutrophil Cytoplasmic Antibody-associated Vasculitis Compared to the General Population.
    J Rheumatol. 2017;44:314-318.
    PubMed     Text format     Abstract available


  77. AESCHLIMANN FA, Angst F, Hofer KD, Cannizzaro Schneider E, et al
    Prevalence of Anti-infliximab Antibodies and Their Associated Co-factors in Children with Refractory Arthritis and/or Uveitis: A Retrospective Longitudinal Cohort Study.
    J Rheumatol. 2017;44:334-341.
    PubMed     Text format     Abstract available


  78. STOUSTRUP P, Twilt M, Spiegel L, Kristensen KD, et al
    Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research Studies.
    J Rheumatol. 2017;44:326-333.
    PubMed     Text format     Abstract available


    February 2017
  79. TEKTONIDOU MG, Ward MM
    Methodological Quality of Studies of Endstage Renal Disease in Lupus Nephritis, 1970 to 2015.
    J Rheumatol. 2017 Feb 15. pii: jrheum.160546. doi: 10.3899/jrheum.160546.
    PubMed     Text format     Abstract available


  80. TANSLEY SL, Betteridge ZE, Simou S, Jacques TS, et al
    Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
    J Rheumatol. 2017 Feb 15. pii: jrheum.160871. doi: 10.3899/jrheum.160871.
    PubMed     Text format     Abstract available


  81. NODA K, Yoshida K, Ukichi T, Furuya K, et al
    Myalgia in Patients with Dermatomyositis and Polymyositis Is Attributable to Fasciitis Rather Than Myositis: A Retrospective Study of 32 Patients who Underwent Histopathological Examinations.
    J Rheumatol. 2017 Feb 1. pii: jrheum.160763. doi: 10.3899/jrheum.160763.
    PubMed     Text format     Abstract available


  82. GUZMAN J, Henrey A, Loughin T, Berard RA, et al
    Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort.
    J Rheumatol. 2017;44:230-240.
    PubMed     Text format     Abstract available


  83. FURUTA S, Chaudhry AN, Arimura Y, Dobashi H, et al
    Comparison of the Phenotype and Outcome of Granulomatosis with Polyangiitis Between UK and Japanese Cohorts.
    J Rheumatol. 2017;44:216-222.
    PubMed     Text format     Abstract available


    January 2017
  84. DE BOYSSON H, Liozon E, Lariviere D, Samson M, et al
    Giant Cell Arteritis-related Stroke: A Retrospective Multicenter Case-control Study.
    J Rheumatol. 2017 Jan 15. pii: jrheum.161033. doi: 10.3899/jrheum.161033.
    PubMed     Text format     Abstract available


  85. GOLDER V, Morand EF, Hoi AY
    Quality of Care for Systemic Lupus Erythematosus: Mind the Knowledge Gap.
    J Rheumatol. 2017 Jan 15. pii: jrheum.160334. doi: 10.3899/jrheum.160334.
    PubMed     Text format     Abstract available


  86. MOGHADAM-KIA S, Oddis CV, Sato S, Kuwana M, et al
    Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
    J Rheumatol. 2017 Jan 15. pii: jrheum.160682. doi: 10.3899/jrheum.160682.
    PubMed     Text format     Abstract available


  87. ORQUEVAUX P, Masseau A, Le Guern V, Gayet V, et al
    In Vitro Fertilization in 37 Women with Systemic Lupus Erythematosus or Antiphospholipid Syndrome: A Series of 97 Procedures.
    J Rheumatol. 2017 Jan 15. pii: jrheum.160462. doi: 10.3899/jrheum.160462.
    PubMed     Text format     Abstract available


  88. ZHU CM, Ma Y, Xie L, Huang JZ, et al
    Spatial Working Memory Impairment in Patients with Non-neuropsychiatric Systemic Lupus Erythematosus: A Blood-oxygen-level Dependent Functional Magnetic Resonance Imaging Study.
    J Rheumatol. 2017 Jan 15. pii: jrheum.160290. doi: 10.3899/jrheum.160290.
    PubMed     Text format     Abstract available


  89. THOMAS G, Cohen Aubart F, Chiche L, Haroche J, et al
    Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients.
    J Rheumatol. 2017;44:24-32.
    PubMed     Text format     Abstract available


    December 2016
  90. CHEN YX, Xu J, Pan XX, Shen PY, et al
    Histopathological Classification and Renal Outcome in Patients with Antineutrophil Cytoplasmic Antibodies-associated Renal Vasculitis: A Study of 186 Patients and Metaanalysis.
    J Rheumatol. 2016 Dec 15. pii: jrheum.160866.
    PubMed     Text format     Abstract available


  91. RICHTER JG, Sander O, Schneider M
    Causes of Cardiovascular Ischemic Events in Giant Cell Arteritis.
    J Rheumatol. 2016;43:2092-2093.
    PubMed     Text format    


  92. AGGARWAL R, Dhillon N, Fertig N, Koontz D, et al
    A Negative Antinuclear Antibody Does Not Indicate Autoantibody Negativity in Myositis: Role of Anticytoplasmic Antibody as a Screening Test for Antisynthetase Syndrome.
    J Rheumatol. 2016 Dec 1. pii: jrheum.160618.
    PubMed     Text format     Abstract available


    November 2016
  93. ARMSTRONG SM, Wither JE, Borowoy AM, Landolt-Marticorena C, et al
    Development, Sensibility, and Validity of a Systemic Autoimmune Rheumatic Disease Case Ascertainment Tool.
    J Rheumatol. 2016 Nov 1. pii: jrheum.160327.
    PubMed     Text format     Abstract available


  94. MOHAMMAD AJ, Englund M, Turesson C, Tomasson G, et al
    Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
    J Rheumatol. 2016 Nov 1. pii: jrheum.160249.
    PubMed     Text format     Abstract available


  95. HUBER AM, Kim S, Reed AM, Carrasco R, et al
    Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash.
    J Rheumatol. 2016 Nov 1. pii: jrheum.160688.
    PubMed     Text format     Abstract available


  96. LOPEZ DE PADILLA CM, Crowson CS, Hein MS, Pendegraft RS, et al
    Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis.
    J Rheumatol. 2016 Nov 1. pii: jrheum.160293.
    PubMed     Text format     Abstract available


    October 2016
  97. FAURSCHOU M, Ahlstrom MG, Lindhardsen J, Obel N, et al
    Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.
    J Rheumatol. 2016 Oct 15. pii: jrheum.160797.
    PubMed     Text format     Abstract available


  98. LAROCHE M, Seniow M, Roche H, Ruyssen-Witrand A, et al
    Arthralgia Associated with Autoimmune Abnormalities under Aromatase Inhibitor Therapy: Outcome after Cessation of Treatment.
    J Rheumatol. 2016;43:1945-1946.
    PubMed     Text format    


    September 2016
  99. GAO R, Yu W, Wen Y, Li H, et al
    Beta2-glycoprotein I Expression in Lupus Nephritis Patients with Antiphospholipid-associated Nephropathy.
    J Rheumatol. 2016 Sep 15. pii: jrheum.151395.
    PubMed     Text format     Abstract available


  100. BACHMEYER C, Galmiche S, Fayand A, Degachi A, et al
    Mycophenolate Mofetil in Refractory Cutaneous Lupus Erythematosus: No Definitive Evidence.
    J Rheumatol. 2016;43:1766.
    PubMed     Text format    


  101. SINGH JA, Hossain A, Kotb A, Oliveira A, et al
    Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis.
    J Rheumatol. 2016 Sep 1. pii: jrheum.160041.
    PubMed     Text format     Abstract available


  102. FORTIN PR, Cloutier N, Bissonnette V, Aghdassi E, et al
    Distinct Subtypes of Microparticle-containing Immune Complexes Are Associated with Disease Activity, Damage, and Carotid Intima-media Thickness in Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Sep 1. pii: jrheum.160050.
    PubMed     Text format     Abstract available


  103. PUGNET G, Sailler L, Fournier JP, Bourrel R, et al
    Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study.
    J Rheumatol. 2016 Sep 1. pii: jrheum.151500.
    PubMed     Text format     Abstract available


    August 2016
  104. GONZALEZ-GAY MA, Castaneda S, Llorca J
    Giant Cell Arteritis: Visual Loss Is Our Major Concern.
    J Rheumatol. 2016;43:1458-61.
    PubMed     Text format    


  105. NANDIWADA SL, Peterson LK, Mayes MD, Jaskowski TD, et al
    Ethnic Differences in Autoantibody Diversity and Hierarchy: More Clues from a US Cohort of Patients with Systemic Sclerosis.
    J Rheumatol. 2016 Aug 1. pii: jrheum.160106.
    PubMed     Text format     Abstract available


  106. HERNANDEZ-MOLINA G, Nunez-Alvarez C, Avila-Casado C, Llorente L, et al
    Usefulness of IgA Anti-alpha-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjogren Syndrome with Negative Anti-SSA/SSB Antibodies.
    J Rheumatol. 2016 Aug 1. pii: jrheum.151315.
    PubMed     Text format     Abstract available


    July 2016
  107. PEREZ-FERRO M, Serrano Del Castillo C, Sanchez-Pernaute O
    Cell Membrane-bound TLR2 and TLR4: Potential Predictors of Active Systemic Lupus Erythematosus and Lupus Nephritis.
    J Rheumatol. 2016;43:1444-5.
    PubMed     Text format    


  108. HERRINTON LJ, Liu L, Goldfien R, Michaels MA, et al
    Risk of Serious Infection for Patients with Systemic Lupus Erythematosus Starting Glucocorticoids with or without Antimalarials.
    J Rheumatol. 2016 Jul 1. pii: jrheum.150671.
    PubMed     Text format     Abstract available


    June 2016
  109. MANFREDI A, Sebastiani M, Campomori F, Pipitone N, et al
    Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern.
    J Rheumatol. 2016 Jun 15. pii: jrheum.160122.
    PubMed     Text format     Abstract available


  110. CAO H, Xia Q, Pan M, Zhao X, et al
    Gottron Papules and Gottron Sign with Ulceration: A Distinctive Cutaneous Feature in a Subset of Patients with Classic Dermatomyositis and Clinically Amyopathic Dermatomyositis.
    J Rheumatol. 2016 Jun 15. pii: jrheum.160024.
    PubMed     Text format     Abstract available


  111. ROBERTS JE, Mandl LA, Su EP, Mayman DJ, et al
    Patients with Systemic Lupus Erythematosus Have Increased Risk of Short-term Adverse Events after Total Hip Arthroplasty.
    J Rheumatol. 2016 Jun 15. pii: jrheum.151373.
    PubMed     Text format     Abstract available


  112. CHEN D, Xie J, Chen H, Yang Y, et al
    Infection in Southern Chinese Patients with Systemic Lupus Erythematosus: Spectrum, Drug Resistance, Outcomes, and Risk Factors.
    J Rheumatol. 2016 Jun 15. pii: jrheum.151523.
    PubMed     Text format     Abstract available


  113. JOO YB, Park SY, Won S, Bae SC, et al
    Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study.
    J Rheumatol. 2016 Jun 1. pii: jrheum.151129.
    PubMed     Text format     Abstract available


  114. SALEH M, Turesson C, Englund M, Merkel PA, et al
    Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study.
    J Rheumatol. 2016 Jun 1. pii: jrheum.151033.
    PubMed     Text format     Abstract available


  115. NUSMAN CM, Rosendahl K, Maas M
    MRI Protocol for the Assessment of Juvenile Idiopathic Arthritis of the Wrist: Recommendations from the OMERACT MRI in JIA Working Group and Health-e-Child.
    J Rheumatol. 2016;43:1257-8.
    PubMed     Text format    


    May 2016
  116. REGENT A, Redeker S, Deroux A, Kieffer P, et al
    Tocilizumab in Giant Cell Arteritis: A Multicentre Retrospective Study of 34 Patients.
    J Rheumatol. 2016 May 15. pii: jrheum.151252.
    PubMed     Text format     Abstract available


  117. CHATRE C, Filippi N, Roubille F, Pers YM, et al
    Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease.
    J Rheumatol. 2016;43:997-8.
    PubMed     Text format    


  118. SUYAMA Y, Nakayama S, Hagiwara K
    Synovial Chondromatosis of the Suprapatellar Pouch of the Knee in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2016;43:948.
    PubMed     Text format    


  119. KNIGHT AM, Xie M, Mandell DS
    Disparities in Psychiatric Diagnosis and Treatment for Youth with Systemic Lupus Erythematosus: Analysis of a National US Medicaid Sample.
    J Rheumatol. 2016 May 1. pii: jrheum.150967.
    PubMed     Text format     Abstract available


  120. ZHAO L, Xu D, Qiao L, Zhang X, et al
    Bone Marrow Megakaryocytes May Predict Therapeutic Response of Severe Thrombocytopenia in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2016 May 1. pii: jrheum.150829.
    PubMed     Text format     Abstract available


  121. HARA A, Furuichi K, Yamahana J, Yasuda H, et al
    Effect of Autoantibodies to Erythropoietin Receptor in Systemic Lupus Erythematosus with Biopsy-proven Lupus Nephritis.
    J Rheumatol. 2016 May 1. pii: jrheum.151430.
    PubMed     Text format     Abstract available


  122. HERMANSEN MF, Lindhardsen J, Torp-Pedersen C, Faurschou M, et al
    Incidence of Systemic Lupus Erythematosus and Lupus Nephritis in Denmark: A Nationwide Cohort Study.
    J Rheumatol. 2016 May 1. pii: jrheum.151221.
    PubMed     Text format     Abstract available


  123. MORA C, Medina-Rosas J, Santos AM, Jaimes DA, et al
    Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus.
    J Rheumatol. 2016 May 1. pii: jrheum.150486.
    PubMed     Text format     Abstract available


  124. LIOZON E, Dalmay F, Lalloue F, Gondran G, et al
    Risk Factors for Permanent Visual Loss in Biopsy-proven Giant Cell Arteritis: A Study of 339 Patients.
    J Rheumatol. 2016 May 1. pii: jrheum.151135.
    PubMed     Text format     Abstract available


    April 2016
  125. LEGGE A, Doucette S, Hanly JG
    Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Apr 15. pii: jrheum.150985.
    PubMed     Text format     Abstract available


  126. ROBSON JC, Kiran A, Maskell J, Hutchings A, et al
    Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study.
    J Rheumatol. 2016 Apr 15. pii: jrheum.151024.
    PubMed     Text format     Abstract available


  127. ZHOU D, Wang Y, Chen LU, Zhang W, et al
    Soluble CD163: A Novel Biomarker with Diagnostic and Therapeutic Implications in Autoimmune Diseases.
    J Rheumatol. 2016;43:830-1.
    PubMed     Text format    


  128. KERMANI TA, Cuthbertson D, Carette S, Hoffman GS, et al
    The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis.
    J Rheumatol. 2016 Apr 1. pii: jrheum.151063.
    PubMed     Text format     Abstract available


  129. AKSOY A, Solmaz D, Can G, Cetin P, et al
    Increased Frequency of Hand Osteoarthritis in Patients with Primary Sjogren Syndrome Compared with Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Apr 1. pii: jrheum.150841.
    PubMed     Text format     Abstract available


  130. CHALAN P, Bijzet J, Kroesen BJ, Boots AM, et al
    Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis are Associated with Autoantibody Status.
    J Rheumatol. 2016 Apr 1. pii: jrheum.150644.
    PubMed     Text format     Abstract available


  131. KNIGHT AM, Vickery ME, Muscal E, Davis AM, et al
    Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada.
    J Rheumatol. 2016 Apr 1. pii: jrheum.151228.
    PubMed     Text format     Abstract available


  132. CONSOLARO A, Ravelli A
    Unraveling the Phenotypic Variability of Juvenile Idiopathic Arthritis across Races or Geographic Areas--Key to Understanding Etiology and Genetic Factors?
    J Rheumatol. 2016;43:683-5.
    PubMed     Text format    


  133. MEDAVARAM S, Xue F, Lahita R
    IgG4 Syndrome Presenting as Leptomeningitis in a Young Woman.
    J Rheumatol. 2016;43:828-9.
    PubMed     Text format    


  134. CONSTANTIN T, Foeldvari I, Vojinovic J, Horneff G, et al
    Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis.
    J Rheumatol. 2016;43:816-24.
    PubMed     Text format     Abstract available


  135. EVENSEN K, Aulie HA, Ronning OM, Flato B, et al
    Carotid Atherosclerosis in Adult Patients with Persistently Active Juvenile Idiopathic Arthritis Compared with Healthy Controls.
    J Rheumatol. 2016;43:810-5.
    PubMed     Text format     Abstract available


  136. FITZPATRICK L, Broadaway KA, Ponder L, Angeles-Han ST, et al
    Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children.
    J Rheumatol. 2016;43:799-803.
    PubMed     Text format     Abstract available


  137. EHRMANN FELDMAN D, Vinet E, Bernatsky S, Duffy C, et al
    Birth Outcomes in Women with a History of Juvenile Idiopathic Arthritis.
    J Rheumatol. 2016;43:804-9.
    PubMed     Text format     Abstract available


    March 2016
  138. KIM K, Bang SY, Joo YB, Kim T, et al
    Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.
    J Rheumatol. 2016 Mar 15. pii: jrheum.150665.
    PubMed     Text format     Abstract available



  139. Specific Antinuclear Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis Are Associated with Improvement of Skin Thickening.
    J Rheumatol. 2016;43:681.
    PubMed     Text format    


    February 2016
  140. UROWITZ MB, Ibanez D, Su J, Gladman DD, et al
    Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Feb 15. pii: jrheum.150983.
    PubMed     Text format     Abstract available


  141. GLUSHKO T, Marcus VA, Colmegna I
    Cytomegalovirus-induced Colon Perforation in Systemic Lupus Erythematosus.
    J Rheumatol. 2016;43:459-60.
    PubMed     Text format    


  142. PEK EA, Joseph PL, Al Habeeb AS, Albert LJ, et al
    A Fatal Case of Calciphylaxis in a Patient with Systemic Lupus Erythematosus and Normal Renal Function.
    J Rheumatol. 2016;43:456-8.
    PubMed     Text format    


  143. DURCAN L, Winegar DA, Connelly MA, Otvos JD, et al
    Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy.
    J Rheumatol. 2016 Feb 1. pii: jrheum.150437.
    PubMed     Text format     Abstract available


  144. KAPUSTA MA
    A Portrait of Juvenile Arthritis with Multiple Joint Abnormalities.
    J Rheumatol. 2016;43:450-1.
    PubMed     Text format    


    January 2016
  145. HINOJOSA-AZAOLA A, Romero-Diaz J, Vargas-Ruiz AG, Nunez-Alvarez CA, et al
    Venous and Arterial Thrombotic Events in Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150506.
    PubMed     Text format     Abstract available


  146. TSELIOS K, Gladman DD, Su J, Urowitz MB, et al
    Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150779.
    PubMed     Text format     Abstract available


  147. ALSOLAIMANI RS, Bhavsar SV, Khalidi NA, Pagnoux C, et al
    Severe Intracranial Involvement in Giant Cell Arteritis: 5 Cases and Literature Review.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150143.
    PubMed     Text format     Abstract available


  148. BROYDE A, Arad U, Madar-Balakirski N, Paran D, et al
    Longterm Efficacy of an Antipneumococcal Polysaccharide Vaccine among Patients with Autoimmune Inflammatory Rheumatic Diseases.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150397.
    PubMed     Text format     Abstract available


  149. HUANG X, Magder LS, Petri M
    Predictors of Incident Seizure in Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150135.
    PubMed     Text format     Abstract available


  150. ZHANG L, Xu D, Yang H, Tian X, et al
    Clinical Features, Morbidity, and Risk Factors of Intestinal Pseudo-obstruction in Systemic Lupus Erythematosus: A Retrospective Case-control Study.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150074.
    PubMed     Text format     Abstract available


  151. HO RC, Ong H, Thiaghu C, Lu Y, et al
    Genetic Variants That Are Associated with Neuropsychiatric Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150884.
    PubMed     Text format     Abstract available


  152. ROTHSCHILD B
    Serine Proteases in Systemic Lupus Erythematosus: The Other Half of the Story.
    J Rheumatol. 2016;43:253.
    PubMed     Text format    


  153. BONROY C, Smith V, Deschepper E, DE Keyser F, et al
    Specific Antinuclear Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis Are Associated with Improvement of Skin Thickening.
    J Rheumatol. 2016;43:247-9.
    PubMed     Text format    


  154. LI YC, Yeh FC, Chen HC
    Extensive Lipoatrophy on a Buttock Revealing Systemic Lupus Erythematosus Panniculitis.
    J Rheumatol. 2016;43:180-1.
    PubMed     Text format    


  155. SASAKI H, Yamazaki H, Kohsaka H
    A Case of ANCA-associated Large Vessel Vasculitis with Multiple Saccular Aneurysms.
    J Rheumatol. 2016;43:179.
    PubMed     Text format    


  156. MCGEOCH L, Twilt M, Famorca L, Bakowsky V, et al
    CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides.
    J Rheumatol. 2016;43:97-120.
    PubMed     Text format     Abstract available


  157. NUSMAN CM, Ording Muller LS, Hemke R, Doria AS, et al
    Current Status of Efforts on Standardizing Magnetic Resonance Imaging of Juvenile Idiopathic Arthritis: Report from the OMERACT MRI in JIA Working Group and Health-e-Child.
    J Rheumatol. 2016;43:239-44.
    PubMed     Text format     Abstract available


    December 2015
  158. PEREZ-PENATE GM, Rua-Figueroa I, Julia-Serda G, Leon-Marrero F, et al
    Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Prevalence and Predictors.
    J Rheumatol. 2015 Dec 15. pii: jrheum.150451.
    PubMed     Text format     Abstract available


  159. XU D, Huang CC, Kachaochana A, Morgan GA, et al
    MicroRNA-10a Regulation of Proinflammatory Mediators: An Important Component of Untreated Juvenile Dermatomyositis.
    J Rheumatol. 2015 Dec 1. pii: jrheum.141474.
    PubMed     Text format     Abstract available


  160. KAY SD, Poulsen MK, Diederichsen AC, Voss A, et al
    Coronary, Carotid, and Lower-extremity Atherosclerosis and Their Interrelationship in Danish Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2015 Dec 1. pii: jrheum.150488.
    PubMed     Text format     Abstract available


    November 2015
  161. YANG Y, Kumar S, Lim LS, Silverman ED, et al
    Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2015 Nov 15. pii: jrheum.150464.
    PubMed     Text format     Abstract available


  162. SABIO JM, Martinez-Bordonado J, Sanchez-Berna I, Vargas-Hitos JA, et al
    Nighttime Blood Pressure Patterns and Subclinical Atherosclerosis in Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2015 Nov 15. pii: jrheum.150531.
    PubMed     Text format     Abstract available


  163. TSELIOS K, Sheane BJ, Gladman DD, Urowitz MB, et al
    Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review.
    J Rheumatol. 2015 Nov 15. pii: jrheum.150460.
    PubMed     Text format     Abstract available


  164. STEIMAN AJ, Gladman DD, Ibanez D, Noamani B, et al
    Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
    J Rheumatol. 2015 Nov 15. pii: jrheum.150040.
    PubMed     Text format     Abstract available


  165. SILVA MF, Ferriani MP, Terreri MT, Pereira RM, et al
    A Multicenter Study of Invasive Fungal Infections in Patients with Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2015 Nov 15. pii: jrheum.150142.
    PubMed     Text format     Abstract available


  166. KILIC E, Kilic G, Ozgocmen S
    Diurnal Variation in Distal Femoral Cartilage Thickness.
    J Rheumatol. 2015;42:2215.
    PubMed     Text format    


    September 2015
  167. STOLL ML, Vaid YN, Guleria S, Beukelman T, et al
    Magnetic Resonance Imaging Findings following Intraarticular Infliximab Therapy for Refractory Temporomandibular Joint Arthritis among Children with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2015 Sep 1. pii: jrheum.150308.
    PubMed     Text format     Abstract available


    June 2015
  168. LOCHBUHLER N, Saurenmann RK, Muller L, Kellenberger CJ, et al
    Magnetic Resonance Imaging Assessment of Temporomandibular Joint Involvement and Mandibular Growth Following Corticosteroid Injection in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2015 Jun 1. pii: jrheum.141502.
    PubMed     Text format     Abstract available


    May 2015
  169. SALTMAN AP, Tseng E, Bunce PE, Albert L, et al
    Double trouble: a case of concurrent opportunistic infections.
    J Rheumatol. 2015;42:903-4.
    PubMed     Text format    


  170. SHUKLA A, Gaur P, Aggarwal A
    Tenascin-C Levels, A Toll-like Receptor 4 Ligand, in Enthesitis-related Arthritis Category of Juvenile Idiopathic Arthritis: A Cross-sectional and Longitudinal Study.
    J Rheumatol. 2015;42:891-6.
    PubMed     Text format     Abstract available


    April 2015
  171. SANTIAGO MB, Machicado V, Ribeiro DS
    "Mutilans-type" Jaccoud Arthropathy.
    J Rheumatol. 2015;42:725-6.
    PubMed     Text format    


  172. YOKOTA S, Itoh Y, Morio T, Sumitomo N, et al
    Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.
    J Rheumatol. 2015;42:712-22.
    PubMed     Text format     Abstract available


  173. TAPPEINER C, Miserocchi E, Bodaghi B, Kotaniemi K, et al
    Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis.
    J Rheumatol. 2015;42:706-11.
    PubMed     Text format     Abstract available


  174. KNIGHT A, Hjorton K, Sundstrom C, Hoglund M, et al
    Leukemia and myelodysplastic syndrome in granulomatosis with polyangiitis: subtypes, clinical characteristics, and outcome.
    J Rheumatol. 2015;42:690-4.
    PubMed     Text format     Abstract available


    March 2015
  175. MAGNI-MANZONI S
    Ultrasound measurement of cartilage thickness in childhood arthritis - target the tissue, tailor the technique.
    J Rheumatol. 2015;42:360-2.
    PubMed     Text format    


  176. BURCHETTE RJ
    Is there hope for juvenile idiopathic arthritis patient-reported outcomes in support of clinical decisions?
    J Rheumatol. 2015;42:358-9.
    PubMed     Text format    


  177. SCHER JU
    Intestinal dysbiosis and potential consequences of microbiome-altering antibiotic use in the pathogenesis of human rheumatic disease.
    J Rheumatol. 2015;42:355-7.
    PubMed     Text format    


  178. PRADSGAARD DO, Fiirgaard B, Spannow AH, Heuck C, et al
    Cartilage thickness of the knee joint in juvenile idiopathic arthritis: comparative assessment by ultrasonography and magnetic resonance imaging.
    J Rheumatol. 2015;42:534-40.
    PubMed     Text format     Abstract available


  179. DIJKSTRA ME, Anink J, van Pelt PA, Hazes JM, et al
    Patient-reported joint count in juvenile idiopathic arthritis: the reliability of a manikin format.
    J Rheumatol. 2015;42:527-33.
    PubMed     Text format     Abstract available


  180. ARVONEN M, Virta LJ, Pokka T, Kroger L, et al
    Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections?
    J Rheumatol. 2015;42:521-6.
    PubMed     Text format     Abstract available


    July 2014
  181. ZHU TY, Griffith JF, Au SK, Tang XL, et al
    Bone Mineral Density Change in Systemic Lupus Erythematosus: A 5-year Followup Study.
    J Rheumatol. 2014 Jul 1. pii: jrheum.131190.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: